Brokerages Set Ralliant Corporation (NYSE:RAL) PT at $75.70

Ralliant Corporation (NYSE:RAL) has been given an average recommendation of “Moderate Buy” by the twelve brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $75.70.

A number of research firms have recently commented on RAL. Zacks Research upgraded Ralliant from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a research report on Friday, July 31st. Oppenheimer lifted their price target on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Barclays lifted their price target on shares of Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a research note on Wednesday, May 13th. Finally, BMO Capital Markets started coverage on shares of Ralliant in a report on Monday, July 20th. They issued a “market perform” rating and a $78.00 price target for the company.

Ralliant Price Performance

NYSE:RAL opened at $63.72 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75. Ralliant has a 52 week low of $37.27 and a 52 week high of $75.41. The stock’s 50-day moving average price is $68.94 and its 200-day moving average price is $55.92. The stock has a market capitalization of $7.05 billion, a PE ratio of -5.87, a price-to-earnings-growth ratio of 2.37 and a beta of 1.60.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. The company had revenue of $567.80 million during the quarter. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities analysts expect that Ralliant will post 2.87 EPS for the current fiscal year.

Ralliant Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a $0.05 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is -1.84%.

Insider Transactions at Ralliant

In related news, CEO Tamara S. Newcombe sold 12,936 shares of the company’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the transaction, the chief executive officer owned 251,967 shares in the company, valued at $18,088,710.93. This represents a 4.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the transaction, the senior vice president owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. This trade represents a 16.07% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by insiders.

Hedge Funds Weigh In On Ralliant

A number of hedge funds have recently made changes to their positions in RAL. Dunhill Financial LLC purchased a new position in shares of Ralliant in the second quarter valued at approximately $25,000. Global Retirement Partners LLC purchased a new stake in shares of Ralliant during the second quarter worth approximately $35,000. Group One Trading LLC purchased a new stake in shares of Ralliant during the second quarter worth approximately $36,000. Danske Bank A S acquired a new position in Ralliant in the 4th quarter valued at $25,000. Finally, Persistent Asset Partners Ltd acquired a new position in Ralliant in the 2nd quarter valued at $37,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.